Skip to main content

Irinotecan Hydrochloride

NDC 67184-0513 · Qilu Pharmaceutical Co., Ltd.

Generic nameIrinotecan Hydrochloride
Dosage formINJECTION, SOLUTION
RouteINTRAVENOUS
Active ingredient(s)IRINOTECAN HYDROCHLORIDE
Strength20 mg/mL
Pharmacologic classTopoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]
Marketing categoryANDA

Packages

67184-0513-1 — 1 VIAL, SINGLE-USE in 1 CARTON (67184-0513-1) / 15 mL in 1 VIAL, SINGLE-USE

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

16714-131 — Irinotecan hydrochloride, 25021-230 — irinotecan hydrochloride, 45963-614 — Irinotecan hydrochloride, 50742-401 — Irinotecan Hydrochloride, 50742-402 — Irinotecan Hydrochloride, 55150-352 — IRINOTECAN HYDROCHLORIDE, 55150-353 — IRINOTECAN HYDROCHLORIDE, 55150-354 — IRINOTECAN HYDROCHLORIDE, 55150-355 — IRINOTECAN HYDROCHLORIDE, 60505-6128 — Irinotecan Hydrochloride, 60505-6272 — Irinotecan Hydrochloride, 61703-349 — Irinotecan Hydrochloride, 63323-193 — IRINOTECAN HYDROCHLORIDE, 67184-0511 — Irinotecan Hydrochloride, 67184-0512 — Irinotecan Hydrochloride, 68001-480 — Irinotecan hydrochloide, 68083-381 — Irinotecan hydrochloide, 68083-382 — Irinotecan hydrochloride, 70700-169 — Irinotecan hydrochloide, 70700-170 — Irinotecan hydrochloride, +8 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.